Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
ReShape Lifesciences Inc
RSLSCurrent price
5.38 USD
-0.43 USD (-7.38%)
Last closed
5.89 USD
Company
www.reshapelifesciences.com
ISIN
US76090R1014
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Capitalization
3 065 383 USD
Yield for 12 month
-63.47 %
1Y
3Y
5Y
10Y
15Y
RSLS
ReShape Lifesciences Inc. provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus. It is also involved in developing ReShape Obalon Balloon System, consists of a swallowable capsule that tracks and displays the location of the balloon during placement; and ReShape Diabetes Bloc-Stim Neuromodulation (DBSN) device, a technology that is in development for the treatment of type 2 diabetes mellitus. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in Irvine, California. Address: 18 Technology Drive, Irvine, CA, United States, 92618
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1 USDP/E ratio
0.2472Dividend Yield
–Current Year
+8 678 000 USD
Last Year
+11 240 000 USD
Current Quarter
+1 965 000 USD
Last Quarter
+1 944 000 USD
Current Year
+5 548 000 USD
Last Year
+6 802 000 USD
Current Quarter
+1 134 000 USD
Last Quarter
+1 165 000 USD
Key Figures RSLS
1 year
3 years
5 years
10 years
EBITDA
-9 193 000 USD
Operating Margin TTM
PE Ratio
0.2472
Return On Assets TTM
-63.46 %
PEG Ratio
–
Return On Equity TTM
-184.59 %
Wall Street Target Price
1 USD
Revenue TTM
8 046 000 USD
Book Value
5.99 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-12.8 %
Dividend Yield
–
Gross Profit TTM
6 802 000 USD
Earnings per share
24.47 USD
Diluted Eps TTM
24.47 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-112.11 %
Dividend Analytics RSLS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History RSLS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:58
Payout Ratio
–
Last Split Date
23.09.2024
Dividend Date
25.07.2019
Stock Valuation RSLS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
0.2472
Forward PE
–
Enterprise Value Revenue
0.2663
Price Sales TTM
0.381
Enterprise Value EBITDA
-0.0159
Price Book MRQ
0.9816
Financials RSLS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators RSLS
For 52 weeks
4.6 USD
23.2 USD
50 Day MA
6.98 USD
Shares Short Prior Month
57 221
200 Day MA
9.93 USD
Short Ratio
0.03
Shares Short
14 680
Short Percent
3.17 %
BeatStart